3-325995-T-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_006614.4(CHL1):āc.128T>Cā(p.Val43Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,611,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006614.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHL1 | NM_006614.4 | c.128T>C | p.Val43Ala | missense_variant | 4/28 | ENST00000256509.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHL1 | ENST00000256509.7 | c.128T>C | p.Val43Ala | missense_variant | 4/28 | 1 | NM_006614.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250262Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135304
GnomAD4 exome AF: 0.0000377 AC: 55AN: 1459766Hom.: 0 Cov.: 29 AF XY: 0.0000262 AC XY: 19AN XY: 726228
GnomAD4 genome AF: 0.000112 AC: 17AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.128T>C (p.V43A) alteration is located in exon 4 (coding exon 2) of the CHL1 gene. This alteration results from a T to C substitution at nucleotide position 128, causing the valine (V) at amino acid position 43 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at